The Exit Strategy: Stocks Showing Critical Warning Signs

November 14, 2026

Every successful investor knows a painful truth: knowing when to sell is often more critical than knowing what to buy.

While financial media overwhelmingly focuses on buying opportunities, our research consistently identifies companies facing significant headwinds that merit serious consideration for selling. These aren’t just stocks underperforming the market; they’re businesses confronting structural challenges, deteriorating fundamentals, or carrying valuations disconnected from financial reality.

What you won’t find here: reactionary calls based on short-term price movements or headline volatility. Each company on this list has been thoroughly analyzed across multiple metrics that historically precede substantial declines.

Smart investors understand that portfolio management requires both addition and subtraction. Sometimes the best investment decision is to redeploy capital away from troubling positions before problems fully materialize in the share price.

This week’s watchlist highlights stocks showing critical weaknesses that demand immediate attention:

Virgin Galactic (SPCE)

Virgin Galactic beat expectations and still lost nearly a quarter of its value in a single morning, because the numbers that beat don’t matter much for a company that currently has no product to sell. Analysts expected a loss of $0.47 per share on sales of about $232,000 for the third quarter. The company reported a loss of $0.39 per share and sales of $430,000. But Virgin Galactic has not flown commercial passengers since it retired its Unity spaceplane in June 2024, and the revenue it reports is minimal while it waits to resume service.

The timeline is what changed the story. Virgin now expects its first Delta-class spaceplane, Apeiron, to make its first commercial flight in early Q2 2027, with a second vehicle following in late Q2 or early Q3 2027. Its fleet is forecast to fly only about 150 times a year by the end of 2028. That is well below the cadence needed to generate positive free cash flow, and it means the company will likely still be burning cash two years from now. Investors who were counting on a faster ramp have been forced to accept a slower one, and the market reacted accordingly.

At around $2 per share, Virgin Galactic has a market capitalization of about $279 million and trades in a 52-week range of $1.81 to $8.90. The stock is down roughly 99% over five years. For space investors, the warning is simple: a company that cannot fly customers is valued on the promise of future flights, and that promise just got further away.

Corteva (CTVA)

Corteva’s third-quarter miss looks a lot like the warning FMC issued last month, and the pattern suggests the pricing pressure in agricultural chemicals is not a one-company problem. Analysts expected $0.10 per share in profit on sales near $1.8 billion. Corteva earned $0.06 per share, and sales came in below $1.6 billion. Shares fell about 20% in Thursday trading. Revenue dropped 9% on a 2% decline in volume, with prices falling 7% as competitors pushed down costs. Sales in Latin America plunged 28%, even as North America, Europe and Asia grew.

The outlook is weaker than the headline guidance suggests. Management described market conditions as “challenging,” particularly in Brazil, and said they will weigh on the agricultural chemicals market “significantly” more than previously expected. It still expects $0.76 to $0.80 per share for the year, but only on an adjusted pro forma operating basis. On a GAAP basis, Wall Street analysts are still looking for $0.82 per share, and that gap is where the disappointment is likely to come from. A 45.58% gross margin is solid, but it is under pressure from the same price declines that have hit the top line.

At around $9 per share, Corteva has a market capitalization of about $6.3 billion and trades near the bottom of its 52-week range of $9.01 to $14.62. The 1.15% dividend yield offers little comfort if pricing keeps falling and the company has to choose between its payout and its investment. For agriculture investors, Corteva’s guidance depends on a pricing environment that is still deteriorating, and the adjusted profit figures management emphasizes are not the numbers the market will ultimately judge.

Koppers Holdings (KOP)

Koppers missed on both sales and profit, and the stock fell more than 24% on the day the report came out. Sales rose to about $499 million from $485 million a year earlier, but analysts had expected $512 million. Adjusted profit dropped to roughly $15 million, or $0.77 per share, from more than $24 million a year earlier, against the $1.34 per share analysts had forecast. The company blamed higher materials and logistics costs, which hit profitability even as volumes rose in its residential and industrial wood preservative businesses.

The guidance cut is the more important signal. Koppers now expects net sales of roughly $1.9 billion, the low end of its prior range, and adjusted earnings of $3.10 to $3.25 per share for the year, down from $3.80 to $4.20. The company raised its free cash flow outlook to $115 million to $135 million, but that is a modest offset. Management also outlined price increases for 2027 to recover higher costs. Those increases will land on railroads, utilities and wood treatment customers who are already cost-sensitive, and that creates a real risk that volumes or margins suffer next.

At around $31 per share, Koppers has a market capitalization of about $586 million and trades in a 52-week range of $26.52 to $53.00. At roughly 10 times the midpoint of its cut earnings guidance, the valuation is not the problem. The problem is that the earnings base is shrinking, and the cost pressures management is trying to pass through to customers may not stick. For materials investors, Koppers is a case where a company’s guidance has moved down faster than its valuation has, and the next few quarters will test whether price hikes can offset costs without costing it customers.



NEXT: